Raltitrexed
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients (NCT05426811) | China Medical University, China | 2022-07-01 |
| Raltitrexed in HIPEC (NCT04761185) | Fudan University | 2020-09-18 |
Track Raltitrexed automatically
Every clearance here is in the API, with alerts when new ones post.